Location: Princeton, NJ
CIK: 0001388551 · Show all filings
Period: Q2 2026 (← Previous)
Filing Date: Aug 14, 2026
Total Value: $1.853M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| SPCX | SPACE EXPLORATION TECHN CORP | 2,606 | $445K | 24.0% | — | — | PUT | 84615Q103 |
| GOOGL | ALPHABET INC | 691 | $247K | 13.3% | — | — | CAP STK CL A | 02079K305 |
| VOO | VANGUARD INDEX FDS | 339 | $233K | 12.6% | — | — | S&P 500 ETF SHS | 922908363 |
| BX | BLACKSTONE INC | 1,597 | $188K | 10.2% | — | — | COM | 09260D107 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| BRK/B | BERKSHIRE HATHAWAY INC DEL | 754 (+3.7%) | $377K (+8.3%) | 20.3% | — | — | CL B NEW | 084670702 |
| LXEO | LEXEO THERAPEUTICS INC | 16,962 (+21.7%) | $78,959 (-1.3%) | 4.3% | — | — | COM | 52886X107 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| GLD | SPDR GOLD TR | 7,623 | $3.28M | 177.0% | — | — | — | 78463V107 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| KYTX | KYVERNA THERAPEUTICS INC | 12,347 (-34.2%) | $110K (-32.1%) | 5.9% | — | — | COM | 501976104 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| IKT | INHIBIKASE THERAPEUTICS INC | 28,453 | $57,759 | 3.1% | — | — | COM NEW | 45719W205 |
| XFOR | X4 PHARMACEUTICALS INC | 15,557 | $72,650 | 3.9% | — | — | COM NEW | 98420X202 |
| ALXO | ALX ONCOLOGY HLDGS INC | 20,946 | $43,358 | 2.3% | — | — | COM | 00166B105 |